Parsons Erin has filed 3 insider transactions across 1 company since June 2024.
Most recent transaction: a grant/award of 20000 shares of KIORA PHARMACEUTICALS INC ($KPRX) on April 01, 2025.
Activity breakdown: 1 open-market purchase and 0 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| April 1, 2025 | KIORA PHARMACEUTICALS INC | $KPRX | Parsons Erin | Director | A | Stock Option (right to buy) | 20000 | $0.00 | 20,000.0000 | 3,000,788 | 9999.99% | 0.67% |
| July 1, 2024 | KIORA PHARMACEUTICALS INC | $KPRX | Parsons Erin | Director | A | Stock Option (right to buy) | 1778 | $0.00 | 1,778.0000 | 2,970,545 | 9999.99% | 0.06% |
| June 13, 2024 | KIORA PHARMACEUTICALS INC | $KPRX | Parsons Erin | Director | P | Common Stock | 5260 | $4.88 | 5,260.0000 | 2,970,545 | 9999.99% | 0.18% |